Asthma and lung cancer risk: A systematic investigation by the international lung cancer consortium

Carcinogenesis

Volumn 33, Issue 3, 2012, Pages 587-597

  Rosenberger, Albert ^a   Bickeböller, Heike ^a   McCormack, Valerie ^b   Brenner, Darren R ^c,d   Duell, Eric J ^e   Tjønneland, Anne ^f   Friis, Soren ^f   Muscat, Joshua E ^g   Yang, Ping ^h   Wichmann, H Erich ^i,j,k   Heinrich, Joachim ⁱ   Szeszenia Dabrowska, Neonila ^l   Lissowska, Jolanta ^m   Zaridze, David ⁿ   Rudnai, Peter ^o   Fabianova, Eleonora ^p   Janout, Vladimir ^q   Bencko, Vladimir ^r   Brennan, Paul ^b   Mates, Dana ^s   Schwartz, Ann G ^t   Cote, Michele L ^t   Zhang, Zuo Feng ^u   Morgenstern, Hal ^v   Oh, Sam S ^w   Field, John K ^x   Raji, Olaide ^w   McLaughlin, John R ^b,c   Wiencke, John ^w   LeMarchand, Loic ^y   Neri, Monica ^z   Bonassi, Stefano ^z   Andrew, Angeline S ^aa   Lan, Qing ^ab   Hu, Wei ^ac   Orlow, Irene ^ac   Park, Bernard J ^ac   Boffetta, Paolo ^ad,ae   Hung, Rayjean J ^c,d   more..

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^f DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^g PENN STATE COLLEGE OF MEDICINE   (United States)

^h MAYO CLINIC   (United States)

ⁱ INSTITUTE OF EPIDEMIOLOGY   (Germany)

^j UNIVERSITY OF MUNICH   (Germany)

^k LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^l NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^m INSTITUTE OF ONCOLOGY   (Poland)

ⁿ N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^o Jozsef Fodor National Center for Public Health   (Hungary)

^p Specialized State Health Institute   (Slovakia)

^q PALACKÝ UNIVERSITY   (Czech Republic)

^r CHARLES UNIVERSITY   (Czech Republic)

^s CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^t WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^u UNIVERSITY OF CALIFORNIA   (United States)

^v UNIVERSITY OF MICHIGAN   (United States)

^w UNIVERSITY OF CALIFORNIA   (United States)

^x UNIVERSITY OF LIVERPOOL   (United Kingdom)

^y University of Hawaii   (United States)

^z IRCCS SAN RAFFAELE PISANA   (Italy)

^aa DARTMOUTH MEDICAL SCHOOL   (United States)

^ab NATIONAL CANCER INSTITUTE   (United States)

^ac MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^ad MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^ae INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASTHMA; CANCER RISK; DISEASE ASSOCIATION; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; PRIORITY JOURNAL; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW;

EID: 84863279846     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr307     Document Type: Article

References (96)

1. Masoli, M. et al. (2004) The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy, 59, 469-478.
2. Fanta, C.H. (2009) Asthma. N. Engl. J. Med., 360, 1002-1014.
3. Beasley, R. et al. (2000) Prevalence and etiology of asthma. J. Allergy Clin. Immunol., 105, S466-S472.
4. Jemal, A. et al. (2011) Global cancer statistics. CA Cancer J. Clin., 61, 69-90.
5. Ezzati, M. et al. (2005) Role of smoking in global and regional cancer epidemiology: current patterns and data needs. Int. J. Cancer, 116, 963-971.
6. Samet, J.M. et al. (2009) Lung cancer in never smokers: clinical epidemiology and environmental risk factors. Clin. Cancer Res., 15, 5626-5645.
7. Wakelee, H.A. et al. (2007) Lung cancer incidence in never smokers. J. Clin. Oncol., 25, 472-478.
8. Fisherman, E.W. et al. (1960) Does the allergic diathesis influencemalignancy? J. Allergy, 31, 74-78.
9. Turner, M.C. et al. (2006) An overview of the association between allergy and cancer. Int. J. Cancer, 118, 3124-3132.
10. Vena, J.E. et al. (1985) Allergy-related diseases and cancer: an inverse association. Am. J. Epidemiol., 122, 66-74.
11. Carrozzi, L. et al. (2005) Allergy and cancer: a biological and epidemiological rebus. Allergy, 60, 1095-1097.
12. Mayne, S.T. et al. (1999) Previous lung disease and risk of lung cancer among men and women nonsmokers. Am. J. Epidemiol., 149, 13-20.
13. Engels, E.A. (2008) Inflammation in the development of lung cancer: epidemiological evidence. Expert. Rev. Anticancer Ther., 8, 605-615.
14. Wang, H. et al. (2005) Is atopy a protective or a risk factor for cancer? A review of epidemiological studies. Allergy, 60, 1098-1111.
15. Sherman, P.W. et al. (2008) Allergies: their role in cancer prevention. Q. Rev. Biol., 83, 339-362.
16. Santillan, A.A. et al. (2003) A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control, 14, 327-334.
17. Wu, A.H. et al. (1995) Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am. J. Epidemiol., 141, 1023-1032.
18. Alavanja, M.C. et al. (1992) Preexisting lung disease and lung cancer among nonsmoking women. Am. J. Epidemiol., 136, 623-632.
19. Vesterinen, E. et al. (1993) Cancer incidence among 78,000 asthmatic patients. Int. J. Epidemiol., 22, 976-982.
20. Ramanakumar, A.V. et al. (2006) Risk of lung cancer following nonmalignant respiratory conditions: evidence from two case-control studies in Montreal, Canada. Lung Cancer, 53, 5-12.
21. Osann, K.E. et al. (2000) Small cell lung cancer in women: risk associated with smoking, prior respiratory disease, and occupation. Lung Cancer, 28, 1-10.
22. Osann, K.E. (1991) Lung cancer in women: the importance of smoking, family history of cancer, and medical history of respiratory disease. Cancer Res., 51, 4893-4897.
23. Littman, A.J. et al. (2004) Prior lung disease and risk of lung cancer in a large prospective study. Cancer Causes Control, 15, 819-827.
24. Liang, H. et al. (2009) Risk of lung cancer following nonmalignant respiratory conditions among nonsmoking women living in Shenyang, Northeast China. J. Womens Health (Larchmt.), 18, 1989-1995.
25. Song, F. et al. (2001) Methods for exploring heterogeneity in meta-analysis. Eval. Health Prof., 24, 126-151.
26. van Houwelingen, H.C. et al. (2002) Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat. Med., 21, 589-624.
27. (2009) Cochrane Handbook for Systematic reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration.
28. Thompson, S.G. et al. (2002) How should meta-regression analyses be undertaken and interpreted? Stat. Med., 21, 1559-1573.
29. Tjonneland, A. et al. (2007) Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand. J. Public Health, 35, 432-441.
30. Cui, Y. et al. (2008) Dietary flavonoid intake and lung cancer-a populationbased case-control study. Cancer, 112, 2241-2248.
31. Sauter, W. et al. (2008) Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer. Cancer Epidemiol. Biomarkers Prev., 17, 1127-1135.
32. Kreienbrock, L. et al. (2001) Case-control study on lung cancer and residential radon in western Germany. Am. J. Epidemiol., 153, 42-52.
33. Kreuzer, M. et al. (2003) Residential radon and risk of lung cancer in Eastern Germany. Epidemiology, 14, 559-568.
34. Holle, R. et al. (2005) KORA-a research platform for population based health research. Gesundheitswesen, 67. Suppl., 1, S19-S25.
35. Brennan, P. et al. (2006) High cumulative risk of lung cancer death among smokers and nonsmokers in Central and Eastern Europe. Am. J. Epidemiol., 164, 1233-1241.
36. Lan, Q. et al. (2000) Indoor coal combustion emissions, GSTM1 and GSTT1 genotypes, and lung cancer risk: a case-control study in Xuan Wei, China. Cancer Epidemiol. Biomarkers Prev., 9, 605-608.
37. The effect of tuberculosis control in China. Lancet, 364, 417-422.
38. Cote, M.L. et al. (2005) Risk of lung cancer among white and black relatives of individuals with early-onset lung cancer. JAMA, 293, 3036-3042.
39. Le Marchand, L. et al. (2000) Intake of flavonoids and lung cancer. J. Natl Cancer Inst., 92, 154-160.
40. Brenner, D.R. et al. (2010) Lung cancer risk in never-smokers: a populationbased case-control study of epidemiologic risk factors. BMC Cancer, 10, 285.
41. Field, J.K. et al. (2005) The Liverpool lung Project research protocol. Int. J. Oncol., 27, 1633-1645.
42. Yang, P. et al. (2004) Glutathione pathway genes and lung cancer risk in young and old populations. Carcinogenesis, 25, 1935-1944.
43. Yang, P. et al. (2005) Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest, 128, 452-462.
44. Heck, J.E. et al. (2009) Lung cancer in a U.S. population with low to moderate arsenic exposure. Environ. Health Perspect., 117, 1718-1723.
45. Muscat, J.E. et al. (1995) Insulation, asbestos, smoking habits, and lung cancer cell types. Am. J. Ind. Med., 27, 257-269.
46. Ugolini, D. et al. (2008) The CREST biorepository: a tool for molecular epidemiology and translational studies on malignant mesothelioma, lung cancer, and other respiratory tract diseases. Cancer Epidemiol. Biomarkers Prev., 17, 3013-3019.
47. Wrensch, M.R. et al. (2005) CYP1A1 variants and smoking-related lung cancer in San Francisco Bay area Latinos and African Americans. Int. J. Cancer, 113, 141-147.
48. Orlow, I. et al. (2008) DNA damage and repair capacity in patients with lung cancer: prediction ofmultiple primary tumors. J. Clin. Oncol., 26, 3560-3566.
49. Schwartz, A.G. et al. (2009) Chronic obstructive lung diseases and risk of non-small cell lung cancer in women. J. Thorac. Oncol., 4, 291-299.
50. Gabriel, R. et al. (1972) Lung cancer and allergy. Br. J. Clin. Pract., 26, 202-204.
51. Markowe, H.L. et al. (1987) Prognosis in adult asthma: a national study. Br. Med. J. (Clin. Res. Ed), 295, 949-952.
52. Brown, D.W. et al. (2005) Asthma and risk of death from lung cancer: nHANES II Mortality Study. J. Asthma, 42, 597-600.
53. Samet, J.M. et al. (1986) Personal and family history of respiratory disease and lung cancer risk. Am. Rev. Respir. Dis., 134, 466-470.
54. Wu, A.H. et al. (1988) Personal and family history of lung disease as risk factors for adenocarcinoma of the lung. Cancer Res., 48, 7279-7284.
55. Brownson, R.C. et al. (2000) Previous lung disease and lung cancer risk among women (United States). Cancer Causes Control, 11, 853-858.
56. Brenner, A.V. et al. (2001) Previous pulmonary diseases and risk of lung cancer in Gansu Province, China. Int. J. Epidemiol., 30, 118-124.
57. Gorlova, O.Y. et al. (2006) Never smokers and lung cancer risk: a casecontrol study of epidemiological factors. Int. J. Cancer, 118, 1798-1804.
58. Wang, H. et al. (2006) Atopic diseases, immunoglobulin E and risk of cancer of the prostate, breast, lung and colorectum. Int. J. Cancer, 119, 695-701.
59. El Zein, M. et al. (2010) History of asthma or eczema and cancer risk among men: a population-based case-control study in Montreal, Quebec, Canada. Ann. Allergy Asthma Immunol., 104, 378-384.
60. Koshiol, J. et al. (2009) Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study. PLoS One, 4, e7380.
61. Gonzalez-Perez, A. et al. (2006) Cancer incidence in a general population of asthma patients. Pharmacoepidemiol. Drug Saf., 15, 131-138.
62. Alderson, M. (1974) Mortality from malignant disease in patients with asthma. Lancet, 2, 1475-1477.
63. Reynolds, P. et al. (1987) Asthma and cancer.Am. J. Epidemiol., 125, 539-540.
64. Boffetta, P. et al. (2002) Lung cancer risk in a population-based cohort of patients hospitalized for asthma in Sweden. Eur. Respir. J., 19, 127-133.
65. Ji, J. et al. (2009) Cancer risk in hospitalised asthma patients. Br. J. Cancer, 100, 829-833.
66. Frostad, A. et al. (2008) Impact of respiratory symptoms on lung cancer: 30-year follow-up of an urban population. Lung Cancer, 60, 22-30.
67. Vandentorren, S. et al. (2003) Long-term mortality among adults with or without asthma in the PAARC study. Eur. Respir. J., 21, 462-467.
68. Eriksson, N.E. et al. (1995) A prospective study of cancer incidence in a cohort examined for allergy. Allergy, 50, 718-722.
69. Huovinen, E. et al. (1997) Mortality of adults with asthma: a prospective cohort study. Thorax, 52, 49-54.
70. Lange, P. et al. (1996) Mortality in adults with self-reported asthma. Copenhagen City heart study group. Lancet, 347, 1285-1289.
71. Mills, P.K. et al. (1992) Allergy and cancer: organ site-specific results from the Adventist Health Study. Am. J. Epidemiol., 136, 287-295.
72. Talbot-Smith, A. et al. (2003) Allergy, atopy, and cancer: a prospective study of the 1981 Busselton cohort. Am. J. Epidemiol., 157, 606-612.
73. Turner, M.C. et al. (2005) Cancer mortality among US men and women with asthma and hay fever. Am. J. Epidemiol., 162, 212-221.
74. Brown, D.W. et al. (2006) Re: asthma and the risk of lung cancer. findings from the Adverse Childhood Experiences (ACE). Cancer Causes Control, 17, 349-350.
75. Salpeter, S.R. et al. (2006) Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Ann. Intern. Med., 144, 904-912.
76. Kenfield, S.A. et al. (2008) Comparison of aspects of smoking among the four histological types of lung cancer. Tob. Control, 17, 198-204.
77. Sobue, T. et al. (2002) Cigarette smoking and subsequent risk of lung cancer by histologic type in middle-aged Japanese men and women: the JPHC study. Int. J. Cancer, 99, 245-251.
78. Burns, D.M. et al. (2011) Do changes in cigarette design influence the rise in adenocarcinoma of the lung? Cancer Causes Control, 22, 13-22.
79. Fitzpatrick, F.A. (2001) Inflammation, carcinogenesis and cancer. Int. Immunopharmacol., 1, 1651-1667.
80. Delgado-Rodriguez, M. et al. (2004) Bias. J. Epidemiol. Commun. Health, 58, 635-641.
81. Kilpelainen, M. et al. (2001) Validation of a new questionnaire on asthma, allergic rhinitis, and conjunctivitis in young adults. Allergy, 56, 377-384.
82. Toren, K. et al. (1993) Asthma and asthma-like symptoms in adults assessed by questionnaires. A literature review. Chest, 104, 600-608.
83. Weissman, D.N. (2002) Epidemiology of asthma: severity matters. Chest, 121, 6-8.
84. Ponsonby, A.L. et al. (2002) Which clinical subgroups within the spectrum of child asthma are attributable to atopy? Chest, 121, 135-142.
85. Brenner, D.B. et al. (2010) Previous lung diseases and lung cancer risk: a pooled analysis from the International lung cancer ConsortiuPrevious lung diseases and lung cancer risk: a pooled analysis from the International lung cancer Consortium. In Preparation.
86. Barnes, P.J. (2006) Against the Dutch hypothesis: asthma and chronic obstructive pulmonary disease are distinct diseases. Am. J. Respir. Crit. Care Med., 174, 240-243.
87. Hanania, N.A. (2005) The challenge of differentiating asthma from chronic obstructive pulmonary disease. Manag. Care, 14, 9-15.
88. Kabesch, M. (2009) Asthma and. what is the link? Curr. Opin. Allergy Clin. Immunol., 9, 393-394.
89. Chhabra, S.K. (2006) Asthma and chronic obstructive pulmonary disease: are they the same or are they distinct diseases? Am. J. Respir. Crit. Care Med., 174, 1056.
90. Brownson, R.C. et al. (1998) Epidemiology and prevention of lung cancer in nonsmokers. Epidemiol. Rev., 20, 218-236.
91. Andersson, E. et al. (1998) Mortality from asthma and cancer among sulfite mill workers. Scand. J. Work Environ. Health, 24, 12-17.
92. Chenard, L. et al. (2007) Lung function and farm size predict healthy worker effect in swine farmers. Chest, 131, 245-254.
93. Toren, K. et al. (1996) Do patients with severe asthma run an increased risk from ischaemic heart disease? Int. J. Epidemiol., 25, 617-620.
94. Fuhrman, C. et al. (2009) Deaths with asthma in France, 2000-2005: a multiple-cause analysis. J. Asthma, 46, 402-406.
95. McCoy, L. et al. (2005) A multiple cause-of-death analysis of asthma mortality in the United States, 1990-2001. J. Asthma, 42, 757-763.
96. Robinette, C.D. et al. (1978) Asthma and subsequent mortality in World War II veterans. J. Chronic. Dis., 31, 619-624.